Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

The VERIGENE^® System

The sample-to-answer, economical, multiplex choice

Enabling clinicians to rapidly identify the pathogens responsible for some of the most complex, costly, and deadly infectious diseases. The VERIGENE^® system provides flexible solutions that allow for closer alignment with clinical and reimbursement guidelines.

VERIGENE^® System main features

Sample-to-answer

Automated sample preparation and test processing take place on the Processor SP, while the test cartridge is placed in the VERIGENE Reader for results.

Minimal hands-on time

All reagents come ready to use and set up time is less than five minutes for all tests.

Easily expandable

Processor SPs are random access and can be easily added to the system to increase testing throughput as workflow needs change.

Direct detection or PCR

VERIGENE^® is unique in that it can provide a molecular result with or without a PCR-amplification step.
Proprietary chemistry allows assays to be tailored to the sample type such as non-amplified blood culture tests.

Why choose
VERIGENE^®

VERIGENE^® rapidly detects pathogens and resistance markers for bloodstream, respiratory, and GI infections. These time-critical results allow clinicians to optimize therapy quickly, leading to better patient outcomes. Sample-to-answer workflow suits both hospital-based and centralized reference labs.

Strong clinical value

Panels are designed to empower clinicians to make decisions that improve patient care and antimicrobial stewardship. Assay targets are tailored to provide maximum impact, following current clinical guidelines.

Economically responsible

Multiplex panels that easily adapt to dynamic reimbursement guidelines. Flexible respiratory testing allows clinicians to order targets by seasonality and patient demographics, while bloodstream infection tests are separated by Gram-stain to save cost.

Unique chemistry

PCR or direct DNA detection is independently used based on the best performance of a particular sample type. Direct DNA detection allows for better accuracy than universal bottle performance for Blood Culture assays.